List of SBIR/STTR awards granted to Bayspec Inc.
Bayspec Inc.Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Bayspec Inc. in February, 2020 for $200,000.0 USD from the U.S. Department of Energy. | STTR | DE-SC0020478 | Phase I | 200,000 | February 18, 2020 | |||||||
A SBIR Phase II contract was awarded to Bayspec Inc. in April, 2020 for $1,099,961.0 USD from the U.S. Department of Defense and United States Army. | SBIR | W911SR-20-C-0037 | Phase II | 1,099,961 | April 30, 2020 | |||||||
A STTR Phase II contract was awarded to Bayspec Inc. in April, 2018 for $999,773.0 USD from the U.S. Department of Defense and United States Army. | STTR | W911 SR-18-C-0015 | Phase II | 999,773 | April 11, 2018 | |||||||
A SBIR Phase II contract was awarded to Bayspec Inc. in December, 2021 for $1,490,938.0 USD from the U.S. Department of Defense and DARPA. | SBIR | W912CG22C0006 | Phase II | 1,490,938 | December 28, 2021 | |||||||
A SBIR Phase I contract was awarded to Bayspec Inc. in July, 2018 for $124,913.0 USD from the U.S. Department of Defense and United States Navy. | SBIR | N68335-18-C-0649 | Phase I | 124,913 | July 2, 2018 | |||||||
A STTR Phase I contract was awarded to Bayspec Inc. in May, 2017 for $149,961.0 USD from the U.S. Department of Defense. | STTR | W81XWH-17-C-0056 | Phase I | 149,961 | May 15, 2017 | |||||||
A STTR Phase I contract was awarded to Bayspec Inc. in September, 2016 for $149,999.0 USD from the U.S. Department of Defense. | STTR | W911SR-16-C-0053 | Phase I | 149,999 | September 9, 2016 | |||||||
A SBIR Phase I contract was awarded to Bayspec Inc. in January, 2011 for $150,000.0 USD from the National Science Foundation. | SBIR | 1047347 | Phase I | 150,000 | January 1, 2011 | |||||||
A SBIR Phase II contract was awarded to Bayspec Inc. for $3,493,403.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N91023C00058 | Phase II | 3,493,403 |
